Furthermore, the E2F2 expression was positively related to cancer purity and negatively related to macrophages, neutrophils, and DCs of GBM; however, the E2F2 expression in GBM showed no significant correlation with CD4+ T cells. The gene discussed is E2F2; the disease is glioblastoma.